Berenberg Downgrades bluebird bio to Hold, Announces $35 Price Target
Berenberg analyst Yun Zhong downgrades bluebird bio (NASDAQ:BLUE) from Buy to Hold and announces $35 price target.
Related Posts
International Money Q1 Adj. EPS $0.34 Beats $0.26 Estimate, Sales $114.70M Beat $112.99M Estimate
International Money (NASDAQ:IMXI) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.26 by 30.77 percent. This is a 25.93 percent increase over earnings of $0.27 per share from
Why Smartsheet Shares Are Sliding After Hours
Smartsheet Inc (NYSE: SMAR) shares are trading lower in Tuesday's after-hours session after the company reported financial results and issued weak earnings guidance.
Record $2.8M Buyout Offer For Declaration Of Independence Rejected: Here Are The Details And How You Can Own It
Fractional investing company Rally Rd has offered investments in sports cards, sports memorabilia, video games, first edition books, wine and automotive. The company has branched out into new asset categories including NFTs.